Research Article

Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study

Table 5

Cox proportional hazards regression analysis identifying predictors of new-onset hypertension.

Baseline and clinical characteristicsModerate or higher hypertensionSevere or crisis-level hypertensionCrisis-level hypertension
Hazard ratio
(95% CI)
P valueHazard ratio
(95% CI)
P ValueHazard ratio
(95% CI)
P value

Gender
 MaleReferenceReferenceReference
 Female1.02 (0.97–1.09)0.421.29 (1.09–1.53)0.00271.28 (1.08–1.51)0.0039
Age
 18–<300.60 (0.42–0.87)0.00730.00 (0.00–>999)0.920.00 (0.00–>999)0.92
 30–<50ReferenceReferenceReference
 50–<651.55 (1.45–1.67)<0.00011.87 (1.49–2.35)<0.00011.87 (1.49–2.34)<0.0001
 ≥652.13 (1.97–2.30)<0.00012.71 (2.13–3.46)<0.00012.74 (2.15–3.50)<0.0001
Year of diagnosis
 2000–20020.95 (0.88–1.02)0.161.20 (0.97–1.49)0.0960.98 (0.79–1.23)0.89
 2003–20050.93 (0.88–0.97)0.00231.10 (0.95–1.26)0.20.97 (0.84–1.12)0.67
 2006–2008ReferenceReferenceReference
Cancer type
 BreastReferenceReferenceReference
 Lung1.20 (1.12–1.29)<0.00011.25 (1.03–1.51)0.0271.38 (1.13–1.67)0.0013
 Colorectal1.33 (1.24–1.43)<0.00011.72 (1.42–2.08)<0.00011.77 (1.46–2.14)<0.0001
 Head and neck1.29 (1.11–1.49)0.00071.55 (1.01–2.37)0.0441.74 (1.13–2.66)0.011
 Gastric1.31 (1.08–1.60)0.00692.14 (1.31–3.47)0.00222.37 (1.46–3.85)0.0005
 Ovarian1.31 (1.16–1.48)<0.00011.89 (1.38–2.57)<0.00011.95 (1.43–2.66)<0.0001
 Cervical1.63 (1.33–2.00)<0.00011.46 (0.75–2.85)0.261.63 (0.84–3.18)0.15
 Renal1.83 (1.57–2.12)<0.00011.52 (0.96–2.42)0.0741.67 (1.05–2.66)0.03
 Melanoma1.07 (0.90–1.26)0.441.31 (0.81–2.13)0.271.41 (0.86–2.29)0.17
 Prostate1.47 (1.32–1.64)<0.00011.47 (1.06–2.04)0.0211.54 (1.11–2.14)0.0095
 Connective and other soft
 tissue
1.32 (1.10–1.58)0.00221.00 (0.51–1.95)0.991.05 (0.54–2.05)0.89
Baseline BP status
 Ideal normal BPReferenceReferenceReference
 Prehypertension2.60 (2.45–2.77)<0.00012.56 (2.13–3.07)<0.00012.54 (2.12–3.05)<0.0001
Clinic type
 HospitalReferenceReferenceReference
 Community0.88 (0.83–0.93)<0.00011.29 (1.09–1.52)0.00261.24 (1.05–1.46)0.01
Health insurance type
 PrivateReferenceReferenceReference
 Public1.18 (1.08–1.28)0.00021.45 (1.12–1.86)0.00421.47 (1.14–1.89)0.0032
 Self1.41 (1.02–1.94)0.0350.38 (0.05–2.69)0.330.39 (0.05–2.81)0.35
 Mixed1.09 (1.01–1.18)0.0261.42 (1.12–1.79)0.00341.41 (1.12–1.78)0.0037
 Other/unknown1.09 (1.03–1.16)0.00571.64 (1.35–1.99)<0.00011.61 (1.33–1.95)<0.0001
Region of residence
 NortheastReferenceReferenceReference
 South1.26 (1.00–1.58)0.0491.75 (0.83–3.70)0.141.68 (0.79–3.55)0.18
 Midwest1.56 (1.23–1.97)0.00022.54 (1.19–5.43)0.0162.42 (1.13–5.17)0.022
 West0.85 (0.67–1.09)0.21.13 (0.52–2.47)0.751.10 (0.51–2.40)0.81
Chemotherapy
 No chemotherapyReferenceReferenceReference
 First-line cytotoxic2.19 (2.07–2.32)<0.00011.98 (1.69–2.33)<0.00012.65 (2.24–3.14)<0.0001
 First-line targeted2.28 (1.90–2.74)<0.00012.99 (1.89–4.73)<0.00013.45 (2.18–5.46)<0.0001
 First-line combination3.39 (3.05–3.76)<0.00013.20 (2.44–4.20)<0.00013.65 (2.78–4.80)<0.0001
 Second-line cytotoxic2.46 (2.18–2.76)<0.00011.66 (1.11–2.49)0.0131.56 (1.04–2.33)0.03
 Second-line targeted3.15 (1.78–5.57)<0.00017.93 (2.52–24.93)0.00046.69 (2.13–21.04)0.0011
 Second-line combination3.52 (3.07–4.05)<0.00012.79 (1.81–4.31)<0.00012.45 (1.59–3.78)<0.0001
 Third-line cytotoxic2.77 (2.18–3.54)<0.00011.60 (0.59–4.30)0.351.22 (0.45–3.28)0.69
 Third-line targeted3.49 (1.45–8.36)0.00528.01 (1.12–57.31)0.0385.44 (0.76–38.88)0.091
 Third-line combination2.50 (1.97–3.17)<0.00011.57 (0.58–4.21)0.371.16 (0.43–3.11)0.77

Ideal normal BP: SBP < 120 mm Hg and DBP < 80 mm Hg. Prehypertension: SBP 120–150 mm Hg or DBP 80–100 mm Hg. Moderate hypertension: 150 mm Hg < SBP ≤ 160 mm Hg or 100 mm Hg < DBP ≤ 110 mm Hg. Severe hypertension: 160 mm Hg < SBP ≤ 180 mm Hg or 110 mm Hg < DBP ≤ 120 mm Hg. Crisis-level hypertension: 180 mm Hg < SBP or 120 mm Hg < DBP. BP: blood pressure; CI: confidence interval; DBP: diastolic blood pressure; SBP: systolic blood pressure.